Zinc supplementation strategies in feedlot heifers receiving an extended-release implant or an aggressive re-implant program

Two hundred eight Angus-crossbred heifers (291 ± 23 kg) from four sources were used in a randomized complete block design. The objective of the study was to determine the effects of implant strategy and Zn supplementation on performance, carcass characteristics, muscle fiber diameter, and mineral status of heifers. Heifers were assigned to a 2 × 2 factorial study for 168 d, and factors included Zn and implant (IMP). Heifers were supplemented Zn (mg/kg dry matter [DM]; ZnSO₄) at national (30; NRC) or industry (100; IND) recommendations. Implant strategies (Merck Animal Health, Madison, NJ) included extended-release Revalor-XH on day 0 (REV-XH; 20 mg estradiol + 200 mg trenbolone acetate) containing four uncoated pellets and six coated pellets or the uncoated implant Revalor-200 on day 0 and again on day 91 (REV-200; 20 mg estradiol + 200 mg trenbolone acetate). Heifers were blocked by weight within source to pens of five or six heifers per pen (nine pens per treatment). A corn silage-based diet was fed during the growing period (days 0–55) followed by transition to a corn-based finishing diet. Weights were taken consecutively on days −1/0, 55/56, and 167/168. Liver and muscle from the longissimus thoracis were collected from one heifer per pen on days −5, 14, 105, and 164. Data were analyzed via Mixed Procedure of SAS. Average daily gain (ADG) and liver mineral used Period as the repeated effect. Corresponding to periods of high hormone payout from each implant, days 0–28 and 91–120 ADG were greatest for REV-200, whereas REV-XH numerically peaked during days 56–91 (IMP × Period; P = 0.02). Day 91 IND body weight tended to be heavier (P = 0.06) and day 120 body weight was heavier (P = 0.05) than NRC heifers. No effect of Zn or IMP on final body weight was observed (P ≥ 0.21). Muscle fiber cross-sectional diameter on day 164 was greater (P = 0.05) in IND than NRC. Liver Mn concentrations decreased by day 14 regardless of implant, though days 105 and 164 concentrations were lesser for REV-200 than REV-XH (IMP × Period; P = 0.02). No effects of Zn, IMP, or the interaction were observed for carcass-adjusted gain to feed, days 0–168 DM intake, hot carcass weight, or ribeye area (P ≥ 0.11). The nominal differences in performance between implant strategies suggest that extended-release implants may be an effective implant strategy to replace re-implant programs in heifers, whereas the improved performance of heifers fed IND vs. NRC during times of peak hormone payout suggests a role for Zn in periods of rapid growth.     

Rhabdomyosarcoma associated with the lead wire of a pacemaker generator implant

An 11‐year‐old female spayed Labrador Retriever was presented for a draining, painful subcutaneous mass palpated over a previously implanted pacemaker generator. Infection was suspected and the mass was removed surgically. On cut surface, the mass was friable and mottled tan to brown with firm pale tan nodules, surrounding the pacemaker lead wire adjacent to the pacemaker generator. Cytologic interpretation of impression smears was consistent with a sarcoma, and suggestive of a rhabdomyosarcoma due to the presence of strap‐like cells. On histopathologic examination, a highly invasive nodular mass surrounded the pacemaker lead, composed of pleomorphic round, spindle and strap cells, and multinucleated giant cells. The population exhibited microscopic invasion into the deep portion of the fibrous capsule surrounding the pacemaker generator. There were tumor emboli within small to medium subcutaneous veins adjacent to the mass. Immunohistochemically, the neoplastic cells stained positive for α‐sarcomeric actin and vimentin, and negative for α‐smooth muscle actin, consistent with a rhabdomyosarcoma arising at the site of the pacemaker generator. To our knowledge, this is the first report of a rhabdomyosarcoma associated with the lead wire of a pacemaker generator in a dog.     

影响微种植钉支抗的临床稳定性因素研究

目的探讨微型种植钉作为增强支抗手段在临床应用中的稳定性,同时分析影响其成功率的相关因素,为今后的临床工作提供参考.方法 53例错颌患者共植入微型种植钉171枚,观察期1 a,并分析年龄、性别、下颌平面角、牙周组织肿胀、牙周炎史等因素对微型种植钉稳定性的影响.结果本组53例错颌患者的微型种植钉总成功率为90.57%（48/53）,其中患者的口腔卫生状况、牙周组织肿胀、牙周炎史、下颌平面角等是微型种植钉成活率的独立影响因素,而且患者的年龄、性别以及微型种植钉的设计因素对微型种植钉成功率的影响无显著性差异,不具有统计学意义（P〉0.05）.结论采用微型种植钉作为增强支抗手段的患者要注意保持口腔清洁,同时医师要根据患者的下颌平面角设计种植方案,避免牙周组织肿胀的发生,以提高微型种植钉的成功率.     

利用干酵母细胞微胶囊化丁香油的研究

探讨以干酵母细胞作为囊壁材料制备微胶囊的可行性。以丁香油为囊芯，通过正交试验优化微胶囊制备的工艺条件。结果表明，选择包埋温度70℃、包埋时间9 h和丁香油与干酵母质量配比为1∶1的条件比较适宜，微胶囊中丁香油包埋率可以达到41.26%。通过光学显微镜和电镜观察，丁香油微胶囊呈规则的球形，颗粒直径在2.0～4.0 μm之间，细胞质内能观察到闪亮的油滴存在。在100℃条件下加热20 h，丁香油经微胶囊化后挥发速率下降43.25%；丁香油微胶囊抑菌效果优于同量的丁香油，具有一定的缓释效果。     

新型液体缓控释制剂在国内的研究进展

液体控释给药系统属多相复合体系,是一种新型药物传递系统。但由于其在贮存中存在着不稳定性,阻碍了许多产品的上市。以立足于新型辅料的应用来解决上述问题为基础,着重介绍了药用级离子交换树脂在控释给药系统中的应用。     

兽用吡喹酮-聚乳酸-羟基乙酸缓释植入棒含量测定及释放度考察

建立了吡喹酮-聚乳酸-羟基乙酸（吡喹酮-PLGA）缓释植入棒含量测定的HPLC法,并对其释放度进行了考察。以甲醇-水（100：40,V／V）为流动相,采用GraceC18反相色谱柱（4．6mm250mm,5μm）,流速1．0mL／min,紫外检测波长263nm,在此试验条件下,吡喹酮在10—200μg／mL范围内与峰面积线性关系良好,r=0．9999;平均回收率为99．48％,RSD为0．53％（n=9）。三批样品的含量分别为98．96％、98．67％和98．81％,该方法简单、快捷、辅料无干扰、准确度高,适于吡喹酮-PLGA植入棒的含量测定。吡喹酮-PLGA植入棒以骨架溶蚀释放机制缓慢释放,释药期可达三周,释放度高于300μg／d。     

Nephrosplenic Space Ablation in Horses After Homologous Pericardium Implant Using a Laparoscopic Stapler

This study aimed to describe and evaluate a laparoscopic technique to promote nephrosplenic space ablation in horses using a homologous pericardium implant, preserved in 98% glycerin and fixed using laparoscopic polydioxanone staples. In this experimental study, six Arabian horses without previous related abdominal diseases were used. The surgical procedures were performed in the standing position under sedation with alpha-2 agonists and opioids, associated with local infiltration of the local anesthetic in the portal sites. The horses were restrained in a stock, and the left flanks were clipped and aseptically prepared. Three portals were created on the left flank, and the homologous pericardium implant, measuring 10 × 5 cm, was introduced into the abdominal cavity covering the nephrosplenic space, positioned between the dorsal border of the spleen and perirenal fascia, fixed with polydioxanone staples using a laparoscopic stapler. Physical examination and blood and peritoneal fluid sample collection were performed on days 0, 1, 3, 7, 14, 30, and 60 of the postoperative period, and an exploratory laparoscopy was performed on day 60 to assess the effectiveness of the technique and eventual complications. There were no difficulties or significant complications during the surgical procedure, and the total average time to perform was 49.83 minutes (±10.19). In the postoperative period, there was a significant increase (P < .05) in the plasma fibrinogen concentration on days 7 and 14 compared with the preoperative moment. The total nucleated cell count in the peritoneal fluid increased (P < .05) on days 1, 3, 7, 14, and 30. After 60 days of the surgical procedure, the physical examination and laboratory data were within the normal range. Exploratory laparoscopy performed on day 60 revealed complete occlusion of the nephrosplenic space, and it was not possible to differentiate the pericardium implant from the scar tissue, not even in the histological evaluation performed on the collected samples. In two horses, omentum adhesion was observed in the region where the implant was fixed, and in two others, a synechia was observed between the implant area and mesocolon without association with clinical complications. The animals were followed up for 36 months at surgery, and no colic signs were observed along this period. It was concluded that the technique of ablation of the nephrosplenic space, using homologous pericardium preserved in 98% glycerin, fixed by polydioxanone staples by laparoscopy, was simple to perform, effective, and free of clinical complications during the period of evaluation, and its use may be indicated as a surgical option in clinical cases of horses with recurrent nephrosplenic entrapment.     

吡唑醚菌酯/二氧化硅微球的释放行为与生物活性评价

为了对二氧化硅载药体系进行评价,以吡唑醚菌酯为模式农药,利用其与正硅酸乙酯在碱性条件下的水解缩合反应,以十六烷基三甲基溴化铵(CTAB)为模板剂,制备了吡唑醚菌酯/二氧化硅微球。通过扫描电子显微镜、Nicolet iS5傅里叶变换红外光谱及高效液相色谱等表征了微球的表面形态和化学结构,测定了其在水中的光解速率;并采用透析袋法探讨了该微球在不同pH值和不同温度下的缓释行为,通过菌丝生长速率法测定了该微球对稻瘟病菌的毒力,评价了其生物活性。结果表明:所制备的吡唑醚菌酯/二氧化硅微球外观形貌较为规整,粒径在0.998~1.428 μm之间,其最大载药量可达50.73%。该微球在碱性条件下的释药速率快于酸性条件下,且其释放均符合一级反应动力学方程,在中性条件下其释药符合Ritger-Peppas方程;与pH值相比,温度对其释药速率的影响较小。给药后第5天,所制备吡唑醚菌酯/二氧化硅微球的毒力与原药相近,给药后第9天,其毒力是原药的11.7倍,缓释效果显著。该吡唑醚菌酯/二氧化硅微球在紫外灯照射10 h后光解率为38.98%,明显低于吡唑醚菌酯原药的光解率(68.92%)。     

荧光标记技术在增殖放流中的应用现状

正标志技术是用来区分不同个体或种群的常用方法。自Petersen等[1]利用标志方法估算封闭水体中鱼类的利用率及种群大小后,标志技术在渔业和水产养殖研究中得到广泛的发展和应用,标记技术也不断更新。荧光标记技术是渔业和水产养殖研究中常用标志技术手段之一,其通过特定技术方法在标志对象上形成荧光标记进而通过肉眼或借